» Articles » PMID: 28950683

Symptom Clusters and Quality of Life in Hospice Patients with Cancer

Overview
Specialty Oncology
Date 2017 Sep 28
PMID 28950683
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Symptom control is an important part of palliative care and important to achieve optimal quality of life (QOL). Studies have shown that patients with advanced cancer suffer from diverse and often severe physical and psychological symptoms. The aim is to explore the influence of symptom clusters on QOL among patients with advanced cancer. Materials and Methods: 709 patients with advanced cancer were recruited to participate in a clinical trial focusing on symptom management and QOL. Patients were adults newly admitted to hospice home care in one of two hospices in southwest Florida, who could pass mental status screening. The instruments used for data collection were the Demographic Data Form, Memorial Symptom Assessment Scale (MSAS), and the Hospice Quality of Life Index-14. Results: Exploratory factor analysis and multiple regression were used to identify symptom clusters and their influence on QOL. The results revealed that the participants experienced multiple concurrent symptoms. There were four symptom clusters found among these cancer patients. Individual symptom distress scores that were the strongest predictors of QOL were: feeling pain; dry mouth; feeling drowsy; nausea; difficulty swallowing; worrying and feeling nervous. Conclusions: Patients with advanced cancer reported various concurrent symptoms, and these form symptom clusters of four main categories. The four symptoms clusters have a negative influence on patients’ QOL and required specific care from different members of the hospice healthcare team. The results of this study should be used to guide health care providers’ symptom management. Proper attention to symptom clusters should be the basis for accurate planning of effective interventions to manage the symptom clusters experienced by advanced cancer patients. The health care provider needs to plan ahead for these symptoms and manage any concurrent symptoms for successful promotion of their patient’s QOL.

Citing Articles

Implementation of pharmaceutical strategies using the PDCA cycle for standardized management of cancer pain medications.

Luo W, Huang H, Zhou Y, Min J, Wang C Support Care Cancer. 2025; 33(3):163.

PMID: 39920344 PMC: 11805850. DOI: 10.1007/s00520-025-09228-9.


Symptom and problem clusters in German specialist palliative home care - a factor analysis of non-oncological and oncological patients' symptom burden.

Gesell D, Hodiamont F, Wikert J, Lehmann-Emele E, Bausewein C, Nauck F BMC Palliat Care. 2023; 22(1):183.

PMID: 37978356 PMC: 10655459. DOI: 10.1186/s12904-023-01296-0.


Xerostomia in patients with advanced cancer: a scoping review of clinical features and complications.

Walsh M, Fagan N, Davies A BMC Palliat Care. 2023; 22(1):178.

PMID: 37950188 PMC: 10638744. DOI: 10.1186/s12904-023-01276-4.


Psychological distress and associated factors among Palestinian advanced cancer patients: A cross-sectional study.

Abu-Odah H, Molassiotis A, Zhao I, Su J, Allsop M Front Psychol. 2022; 13:1061327.

PMID: 36533049 PMC: 9755485. DOI: 10.3389/fpsyg.2022.1061327.


Palliative care and its own identity, through an autoethnography: do you recognize these patterns?.

Neto I Palliat Care Soc Pract. 2022; 16:26323524221122346.

PMID: 36118620 PMC: 9478704. DOI: 10.1177/26323524221122346.


References
1.
McMillan S, Mahon M . Measuring quality of life in hospice patients using a newly developed Hospice Quality of Life Index. Qual Life Res. 1994; 3(6):437-47. DOI: 10.1007/BF00435396. View

2.
Cooley M, Short T, Moriarty H . Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology. 2003; 12(7):694-708. DOI: 10.1002/pon.694. View

3.
Chang V, Hwang S, Feuerman M, Kasimis B . Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer. 2000; 88(5):1175-83. DOI: 10.1002/(sici)1097-0142(20000301)88:5<1175::aid-cncr30>3.0.co;2-n. View

4.
Cohen S, Mount B . Living with cancer: "good" days and "bad" days--what produces them? Can the McGill quality of life questionnaire distinguish between them?. Cancer. 2000; 89(8):1854-65. DOI: 10.1002/1097-0142(20001015)89:8<1854::aid-cncr28>3.0.co;2-c. View

5.
Lenz E, Pugh L, Milligan R, Gift A, Suppe F . The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997; 19(3):14-27. DOI: 10.1097/00012272-199703000-00003. View